Infective endocarditis following transcatheter aortic valve replacement—: Diagnostic and management challenges

Authors

  • Poay Huan Loh MB., BCh., MRCP,

    1. Cardiology Department, The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark
    2. Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom
    Search for more papers by this author
  • Henning Bundgaard MD,

    1. Cardiology Department, The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark
    Search for more papers by this author
  • Lars S⊘ndergaard MD

    Corresponding author
    • Cardiology Department, The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark
    Search for more papers by this author

  • Conflict of interest: Dr. Lars S⊘ndergaard is a proctor for CoreValve, Medtronics.

Correspondence to: Lars Søndergaard, MD, Rigshospitalet University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark. E-mail: lars.00.soendergaard@rh.regionh.dk

Abstract

Transcatheter aortic valve replacement (TAVR) can improve the symptoms and prognosis of patients with severe aortic stenosis who, due to a high expected operative risk, would not have otherwise been treated surgically. If these patients develop prosthetic valve endocarditis, their presentations may be atypical causing a delay in the diagnosis and treatment. The management is also complicated by their comorbidities, and surgical treatment may not be feasible leading to a significant morbidity and mortality. We describe a case of an 85-year-old man with TAVI prosthetic valve endocarditis successfully treated medically, discuss the challenges in the diagnosis and management of such patients, and review available literature on the incidence and outcome of the condition. © 2012 Wiley Periodicals, Inc.

Ancillary